Gilead Sciences (GILD) Shareholder Btr Capital Management Has Cut Its Position by $399,000 as Shares Declined; Wix (WIX) Shareholder Ion Asset Management LTD Has Trimmed Its Position by $2.75 Million as Share Price Rose

December 16, 2017 - By Nellie Frank

Btr Capital Management Inc decreased its stake in Gilead Sciences Inc (GILD) by 9.69% based on its latest 2017Q2 regulatory filing with the SEC. Btr Capital Management Inc sold 5,700 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 53,150 shares of the health care company at the end of 2017Q2, valued at $3.76M, down from 58,850 at the end of the previous reported quarter. Btr Capital Management Inc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $97.92 billion market cap company. The stock decreased 1.45% or $1.1 during the last trading session, reaching $74.96. About 3.79M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since December 16, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Bart Baum decreased its stake in Wix (WIX) by 14.97% based on its latest 2017Q2 regulatory filing with the SEC. Ion Asset Management Ltd sold 39,813 shares as the company’s stock rose 15.82% with the market. The hedge fund run by Bart Baum held 226,103 shares of the programming company at the end of 2017Q2, valued at $15.74M, down from 265,916 at the end of the previous reported quarter. Ion Asset Management Ltd who had been investing in Wix for a number of months, seems to be less bullish one the $2.66B market cap company. The stock decreased 0.26% or $0.15 during the last trading session, reaching $58.4. About 361,446 shares traded. Wix.com Ltd. (NASDAQ:WIX) has risen 188.42% since December 16, 2016 and is uptrending. It has outperformed by 171.72% the S&P500.

Among 14 analysts covering Wix.com (NASDAQ:WIX), 8 have Buy rating, 0 Sell and 6 Hold. Therefore 57% are positive. Wix.com had 30 analyst reports since August 6, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained the shares of WIX in report on Monday, August 21 with “Buy” rating. The firm earned “Overweight” rating on Thursday, November 9 by KeyBanc Capital Markets. RBC Capital Markets downgraded Wix.com Ltd. (NASDAQ:WIX) rating on Friday, September 23. RBC Capital Markets has “Sector Perform” rating and $45 target. Cantor Fitzgerald initiated Wix.com Ltd. (NASDAQ:WIX) on Wednesday, October 19 with “Buy” rating. As per Thursday, February 11, the company rating was maintained by RBC Capital Markets. The stock of Wix.com Ltd. (NASDAQ:WIX) has “Outperform” rating given on Thursday, November 9 by Oppenheimer. The rating was maintained by Deutsche Bank on Thursday, August 6 with “Hold”. RBC Capital Markets maintained Wix.com Ltd. (NASDAQ:WIX) rating on Thursday, July 27. RBC Capital Markets has “Hold” rating and $8100 target. RBC Capital Markets maintained Wix.com Ltd. (NASDAQ:WIX) on Thursday, November 2 with “Hold” rating. On Thursday, August 6 the stock rating was maintained by Oppenheimer with “Outperform”.

Investors sentiment decreased to 0.81 in Q2 2017. Its down 0.57, from 1.38 in 2017Q1. It fall, as 27 investors sold WIX shares while 58 reduced holdings. 30 funds opened positions while 39 raised stakes. 29.90 million shares or 9.87% less from 33.17 million shares in 2017Q1 were reported. Tower Research Limited Liability (Trc) has 619 shares for 0% of their portfolio. Nuveen Asset Mgmt Lc owns 93,611 shares. Connor Clark And Lunn Invest Ltd has 166,917 shares. Suntrust Banks Inc invested 0% of its portfolio in Wix.com Ltd. (NASDAQ:WIX). Eulav Asset Mgmt owns 14,800 shares for 0.05% of their portfolio. Redwood Limited Liability Company holds 0.14% or 19,259 shares in its portfolio. State Bank Of America De holds 0% or 120,084 shares in its portfolio. Retail Bank Of Mellon accumulated 20,831 shares. 157,941 were accumulated by Newbrook Capital Advisors Ltd Partnership. 5,850 were reported by Pacad Invest Ltd. Alliancebernstein LP owns 836,396 shares. D E Shaw & Communication, New York-based fund reported 9,056 shares. Lazard Asset Management Ltd Llc owns 0.01% invested in Wix.com Ltd. (NASDAQ:WIX) for 38,074 shares. Victory Cap Mgmt accumulated 632,990 shares. State Street Corp holds 0% or 150,193 shares.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 EPS, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18 billion for 11.22 P/E if the $1.67 EPS becomes a reality. After $2.23 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Investors sentiment increased to 0.93 in Q2 2017. Its up 0.02, from 0.91 in 2017Q1. It is positive, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Brinker Inc owns 23,194 shares. Natl Bank Va holds 3,216 shares. Florida-based Carl Domino has invested 1.14% in Gilead Sciences, Inc. (NASDAQ:GILD). Public Sector Pension Investment Board holds 0.09% or 149,078 shares. Monetary Mngmt Gp holds 0.79% or 27,145 shares. 38,275 are owned by Stanley Capital Mngmt Limited Liability Co. Sumitomo Mitsui Hldgs Inc owns 3.82 million shares or 0.4% of their US portfolio. Fayez Sarofim & owns 0.18% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 469,151 shares. Eii Capital Mngmt stated it has 0.83% in Gilead Sciences, Inc. (NASDAQ:GILD). Rock Point Advsr Limited Liability Co invested 4.12% in Gilead Sciences, Inc. (NASDAQ:GILD). Bridges Inv Management holds 0.56% or 58,575 shares. 42,880 were reported by Evergreen Cap Management Limited Liability Com. Price T Rowe Md holds 0.19% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 14.98 million shares. Mcclain Value Management Ltd Liability Co has invested 3.78% in Gilead Sciences, Inc. (NASDAQ:GILD). Boston Private Wealth Ltd reported 0.61% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD).

Since August 1, 2017, it had 0 buys, and 9 selling transactions for $36.34 million activity. Meyers James R also sold $4.99M worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares. On Tuesday, August 1 the insider Alton Gregg H sold $1.14M. 51,820 shares were sold by Washington Robin L, worth $4.40 million.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 107 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Wednesday, October 28 by Maxim Group. On Tuesday, July 26 the stock rating was downgraded by Needham to “Hold”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Outperform” rating given on Wednesday, March 23 by Credit Suisse. Jefferies reinitiated Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, July 11. Jefferies has “Hold” rating and $80 target. The firm earned “Strong Buy” rating on Thursday, September 10 by Jyske Bank. Credit Suisse maintained the stock with “Outperform” rating in Wednesday, February 3 report. Maxim Group maintained the stock with “Buy” rating in Wednesday, July 29 report. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, November 2 report. On Wednesday, June 1 the stock rating was initiated by Gabelli with “Buy”. The firm earned “Market Perform” rating on Thursday, October 19 by Leerink Swann.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com